Treatment of mediastinal fibrosis with mycophenolate mofetil

Witschi, Michael; Gugger, Mathias; Nicod, Laurent P (2009). Treatment of mediastinal fibrosis with mycophenolate mofetil. Respiration, 78(3), pp. 330-3. Basel: Karger 10.1159/000209508

Full text not available from this repository. (Request a copy)

We present the case of a 67-year-old male patient with mediastinal and retroperitoneal fibrosis. In Europe, this is a rare disease. Treatment was established to prevent complications due to strictures or compressions. Because of his diabetes, a therapy of low-dose prednisone combined with mycophenolate mofetil, known as steroid sparing agent, was applied. As a result, the radiological follow-up showed a marked decrease in the mediastinal and retroperitoneal masses.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Gugger, Mathias

ISSN:

0025-7931

ISBN:

19295189

Publisher:

Karger

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:08

Last Modified:

04 May 2014 23:21

Publisher DOI:

10.1159/000209508

PubMed ID:

19295189

Web of Science ID:

000268894700015

URI:

https://boris.unibe.ch/id/eprint/29990 (FactScience: 165614)

Actions (login required)

Edit item Edit item
Provide Feedback